135 related articles for article (PubMed ID: 15370596)
1. Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years.
Ferrari C; Benassi S; Ponticelli F; Gamberi G; Ragazzini P; Pazzaglia L; Balladelli A; Bertoni F; Picci P
Acta Orthop Scand; 2004 Aug; 75(4):487-91. PubMed ID: 15370596
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
Korpi JT; Hagström J; Lehtonen N; Parkkinen J; Sorsa T; Salo T; Laitinen M
Surg Oncol; 2011 Mar; 20(1):e18-22. PubMed ID: 20880700
[TBL] [Abstract][Full Text] [Related]
3. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in giant cell tumor of bone: an immunohistochemical study with clinical correlation.
Schoedel KE; Greco MA; Stetler-Stevenson WG; Ohori NP; Goswami S; Present D; Steiner GC
Hum Pathol; 1996 Nov; 27(11):1144-8. PubMed ID: 8912822
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
5. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
[TBL] [Abstract][Full Text] [Related]
6. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
7. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
[TBL] [Abstract][Full Text] [Related]
8. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
[TBL] [Abstract][Full Text] [Related]
9. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
11. Imbalance between Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Promotes Invasion and Metastasis of Head and Neck Squamous Cell Carcinoma.
Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC
Clin Lab; 2017 Oct; 63(10):1613-1620. PubMed ID: 29035450
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL.
Andersen K; Maelandsmo GM; Hovig E; Fodstad O; Loennechen T; Winberg JO
Anticancer Res; 1998; 18(5A):3299-303. PubMed ID: 9858899
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
14. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
16. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.
Choi KH; Lee HB; Jeong MY; Rhee YK; Chung MJ; Kwak YG; Lee YC
Chest; 2002 May; 121(5):1478-85. PubMed ID: 12006432
[TBL] [Abstract][Full Text] [Related]
17. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis.
Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM
J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287
[TBL] [Abstract][Full Text] [Related]
18. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
20. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
